Literature DB >> 26205584

A time-resolved Förster resonance energy transfer assay to measure activity of the deamidase of the prokaryotic ubiquitin-like protein.

Ian C Eustis1, Jessica Huang1, Meagan E Pilkerton1, Samuel D Whedon1, Champak Chatterjee2.   

Abstract

The modification of proteins in Mycobacterium tuberculosis (Mtb) by the prokaryotic ubiquitin-like protein (Pup) targets them for degradation by mycobacterial proteasomes. Although functionally similar to eukaryotic deubiquitylating enzymes, the deamidase of Pup, called Dop, has no known mammalian homologs. Because Dop is necessary for persistent infection by Mtb, its selective inhibition holds potential for tuberculosis therapy. To facilitate high-throughput screens for Dop inhibitors, we developed a time-resolved Förster resonance energy transfer (TR-FRET)-based assay for Dop function. The TR-FRET assay was successfully applied to determine the Michaelis constant for adenosine triphosphate (ATP) binding and to test the cofactor tolerance of Dop. Published by Elsevier Inc.

Entities:  

Keywords:  Deamidase of Pup; Ligase; Prokaryotic ubiquitin-like protein; Pupylation; TR–FRET; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26205584      PMCID: PMC4560620          DOI: 10.1016/j.ab.2015.07.003

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  16 in total

1.  The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

Authors:  Keertan Dheda; Giovanni B Migliori
Journal:  Lancet       Date:  2011-10-25       Impact factor: 79.321

2.  Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes.

Authors:  Frank Striebel; Frank Imkamp; Markus Sutter; Martina Steiner; Azad Mamedov; Eilika Weber-Ban
Journal:  Nat Struct Mol Biol       Date:  2009-05-17       Impact factor: 15.369

3.  TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitors.

Authors:  Charitha Madiraju; Kate Welsh; Michael P Cuddy; Paulo H Godoi; Ian Pass; Tram Ngo; Stefan Vasile; Eduard A Sergienko; Paul Diaz; Shu-Ichi Matsuzawa; John C Reed
Journal:  J Biomol Screen       Date:  2011-10-27

4.  Molecular analysis of the prokaryotic ubiquitin-like protein (Pup) conjugation pathway in Mycobacterium tuberculosis.

Authors:  Francisca A Cerda-Maira; Michael J Pearce; Michele Fuortes; William R Bishai; Stevan R Hubbard; K Heran Darwin
Journal:  Mol Microbiol       Date:  2010-09       Impact factor: 3.501

5.  A time-resolved fluorescence resonance energy transfer-based assay for DEN1 peptidase activity.

Authors:  Ingo H Engels; Catherine Daguia; Truc Huynh; Hugo Urbina; Jörg Buddenkotte; Andrew Schumacher; Jeremy S Caldwell; Achim Brinker
Journal:  Anal Biochem       Date:  2009-03-27       Impact factor: 3.365

6.  Fluorescent probes reveal a minimal ligase recognition motif in the prokaryotic ubiquitin-like protein from Mycobacterium tuberculosis.

Authors:  Denis Smirnov; Abhinav Dhall; Kalkena Sivanesam; Rudy J Sharar; Champak Chatterjee
Journal:  J Am Chem Soc       Date:  2013-02-14       Impact factor: 15.419

7.  Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis.

Authors:  Michael J Pearce; Julian Mintseris; Jessica Ferreyra; Steven P Gygi; K Heran Darwin
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

8.  Pupylated proteins in Corynebacterium glutamicum revealed by MudPIT analysis.

Authors:  Andreas Küberl; Benjamin Fränzel; Lothar Eggeling; Tino Polen; Dirk Andreas Wolters; Michael Bott
Journal:  Proteomics       Date:  2014-05-16       Impact factor: 3.984

9.  PupDB: a database of pupylated proteins.

Authors:  Chun-Wei Tung
Journal:  BMC Bioinformatics       Date:  2012-03-16       Impact factor: 3.169

10.  Synthesis and evaluation of a selective fluorogenic Pup derived assay reagent for Dop, a potential drug target in Mycobacterium tuberculosis.

Authors:  Remco Merkx; Kristin E Burns; Paul Slobbe; Farid El Oualid; Dris El Atmioui; K Heran Darwin; Huib Ovaa
Journal:  Chembiochem       Date:  2012-08-24       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.